Medications for Anxiety Disorders
- 2 June 2023
- book chapter
- Published by Springer Nature
- p. 1-68
Abstract
No abstract availableKeywords
This publication has 348 references indexed in Scilit:
- EFFECTS OF ARIPIPRAZOLE AUGMENTATION IN TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER (A DOUBLE BLIND CLINICAL TRIAL)Depression and Anxiety, 2012
- Long-term Escitalopram Treatment in Korean Patients with Panic Disorder: A Prospective, Naturalistic, Open-label, Multicenter TrialClinical Psychopharmacology and Neuroscience, 2012
- A Randomized, Naturalistic, Parallel-Group Study for the Long-Term Treatment of Panic Disorder With Clonazepam or ParoxetineJournal of Clinical Psychopharmacology, 2012
- Ondansetron Augmentation in Treatment-Resistant Obsessive-Compulsive DisorderCNS Drugs, 2009
- A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind studyBMC Psychiatry, 2009
- Escitalopram for Older Adults With Generalized Anxiety DisorderJAMA, 2009
- Prazosin Effects on Objective Sleep Measures and Clinical Symptoms in Civilian Trauma Posttraumatic Stress Disorder: A Placebo-Controlled StudyBiological Psychiatry, 2008
- Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label studyJournal of Psychopharmacology, 2005
- Efficacy and Tolerability of Citalopram in the Treatment of Late-Life Anxiety Disorders: Results From an 8-Week Randomized, Placebo-Controlled TrialAmerican Journal of Psychiatry, 2005
- Tiagabine for Posttraumatic Stress DisorderThe Journal of Clinical Psychiatry, 2003